Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 47% ± 23% | |
epithelial cell of proximal tubule | 4 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of CYP4A11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 33666.38 | 226 / 226 | 94% | 188.15 | 381 / 406 |
kidney | 100% | 12250.99 | 89 / 89 | 53% | 45.12 | 478 / 901 |
breast | 96% | 53.39 | 441 / 459 | 2% | 0.13 | 25 / 1118 |
adipose | 95% | 58.20 | 1141 / 1204 | 0% | 0 | 0 / 0 |
brain | 86% | 31.62 | 2284 / 2642 | 0% | 0 | 0 / 705 |
thymus | 82% | 18.79 | 538 / 653 | 0% | 0.00 | 1 / 605 |
lung | 81% | 18.84 | 471 / 578 | 1% | 0.08 | 12 / 1155 |
pancreas | 74% | 22.47 | 243 / 328 | 6% | 0.31 | 11 / 178 |
stomach | 79% | 43.72 | 282 / 359 | 0% | 0 | 0 / 286 |
blood vessel | 70% | 15.26 | 935 / 1335 | 0% | 0 | 0 / 0 |
skin | 65% | 15.81 | 1176 / 1809 | 0% | 0.01 | 1 / 472 |
muscle | 64% | 9.97 | 515 / 803 | 0% | 0 | 0 / 0 |
uterus | 62% | 11.98 | 106 / 170 | 0% | 0.01 | 1 / 459 |
prostate | 60% | 8.47 | 147 / 245 | 0% | 0.01 | 2 / 502 |
esophagus | 58% | 8.82 | 837 / 1445 | 1% | 0.06 | 1 / 183 |
bladder | 52% | 9.05 | 11 / 21 | 0% | 0.00 | 1 / 504 |
ovary | 34% | 4.88 | 61 / 180 | 13% | 1.12 | 58 / 430 |
heart | 47% | 7.46 | 405 / 861 | 0% | 0 | 0 / 0 |
intestine | 42% | 17.35 | 407 / 966 | 2% | 0.56 | 8 / 527 |
adrenal gland | 25% | 3.21 | 64 / 258 | 0% | 0.01 | 1 / 230 |
peripheral blood | 21% | 18.52 | 196 / 929 | 0% | 0 | 0 / 0 |
spleen | 12% | 47.40 | 28 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032305 | Biological process | positive regulation of icosanoid secretion |
GO_0043651 | Biological process | linoleic acid metabolic process |
GO_0003091 | Biological process | renal water homeostasis |
GO_0046456 | Biological process | icosanoid biosynthetic process |
GO_0055078 | Biological process | sodium ion homeostasis |
GO_0001822 | Biological process | kidney development |
GO_0048252 | Biological process | lauric acid metabolic process |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0036101 | Biological process | leukotriene B4 catabolic process |
GO_0003095 | Biological process | pressure natriuresis |
GO_0097267 | Biological process | omega-hydroxylase P450 pathway |
GO_0019373 | Biological process | epoxygenase P450 pathway |
GO_0006691 | Biological process | leukotriene metabolic process |
GO_0001676 | Biological process | long-chain fatty acid metabolic process |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0031408 | Biological process | oxylipin biosynthetic process |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0018685 | Molecular function | alkane 1-monooxygenase activity |
GO_0070330 | Molecular function | aromatase activity |
GO_0050051 | Molecular function | leukotriene-B4 20-monooxygenase activity |
GO_0008391 | Molecular function | arachidonic acid monooxygenase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0102033 | Molecular function | long-chain fatty acid omega-hydroxylase activity |
GO_0008392 | Molecular function | arachidonic acid epoxygenase activity |
Gene name | CYP4A11 |
Protein name | Cytochrome P450 family 4 subfamily A member 11 Cytochrome P450 4A11 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYP4AII) (CYPIVA11) (Cytochrome P-450HK-omega) (Cytochrome P450HL-omega) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) |
Synonyms | CYP4A2 |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of fatty acids and their oxygenated derivatives (oxylipins) . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) . Catalyzes predominantly the oxidation of the terminal carbon (omega-oxidation) of saturated and unsaturated fatty acids, the catalytic efficiency decreasing in the following order: dodecanoic > tetradecanoic > (9Z)-octadecenoic > (9Z,12Z)-octadecadienoic > hexadecanoic acid . Acts as a major omega-hydroxylase for dodecanoic (lauric) acid in liver . Participates in omega-hydroxylation of (5Z,8Z,11Z,14Z)-eicosatetraenoic acid (arachidonate) to 20-hydroxyeicosatetraenoic acid (20-HETE), a signaling molecule acting both as vasoconstrictive and natriuretic with overall effect on arterial blood pressure . Can also catalyze the oxidation of the penultimate carbon (omega-1 oxidation) of fatty acids with lower efficiency . May contribute to the degradation of saturated very long-chain fatty acids (VLCFAs) such as docosanoic acid, by catalyzing successive omega-oxidations to the corresponding dicarboxylic acid, thereby initiating chain shortening . Omega-hydroxylates (9R,10S)-epoxy-octadecanoate stereoisomer . Plays a minor role in omega-oxidation of long-chain 3-hydroxy fatty acids . Has little activity toward prostaglandins A1 and E1 . . |
Accessions | ENST00000468629.5 V9GZ77 V9GYC6 ENST00000474458.5 V9GYQ2 A0A0C4DFV7 ENST00000462347.5 ENST00000371905.1 ENST00000465874.5 Q02928 V9GY41 ENST00000310638.9 [Q02928-1] V9GYK4 ENST00000475477.5 |